Breaking News

Why so few get screened for lung cancer; early results for an innovative eye stem cell transplant

August 18, 2023
Adobe

Why so few get screened for lung cancer, the deadliest cancer in the U.S.

A combination of strict eligibility criteria and special coverage requirements means few at high risk get lung cancer screening.

By Simar Bajaj


ProMED sees offers of support, but its future remains unclear

The service's overseers are reported to be in "serious negotiation" with some major universities and "a number of major funders."

By Helen Branswell


STAT+ | An innovative eye stem cell transplant could help restore vision in people with chemical injuries

For some patients whose eyes are damaged in chemical injuries, the stem cell transplant procedure offers new hope.

By Annalisa Merelli



Brianna Celix: Having two autoimmune diseases is "my 'why' for medicine."
Photo illustration: Casey Shenery for STAT

Having celiac disease and a thyroid condition sent her on a quest to become an empathetic doctor

The struggle to correctly diagnose two autoimmune conditions fosters a resolve to become an empathetic doctor.

By Isabella Cueto


Opinion: Medicine robs physicians of their fertility. Here's how to fix it

As a profession, we have started to talk about infertility, but not the negative enduring impacts of family-building journeys.

By Morgan S. Levy and Vineet Arora and Arghavan Salles


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments